Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. [electronic resource]
Producer: 20070306Description: 896-904 p. digitalISSN:- 0006-4971
- Adolescent
- Asparaginase -- therapeutic use
- Cardiotonic Agents -- therapeutic use
- Child
- Child, Preschool
- Combined Modality Therapy
- Cranial Irradiation
- Disease-Free Survival
- Doxorubicin -- therapeutic use
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Infant
- Male
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Razoxane -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.